If you feel tirzepatide is not working as expected, it is important to understand that several factors may influence treatment outcomes
Yes, because BPC-157 is an experimental compound intended for therapeutic use, it should only be used under the supervision of a licensed healthcare provider
Together, slower digestion and a stronger fullness signal sharply reduce the drive to eat, and the weight comes off commonly around 15 percent of body weight with semaglutide and up to roughly 20 percent with tirzepatide in head-to-head clinical trials, though real-world results are often more modest
One concern that has been raised is the occurrence of leg cramps in people taking semaglutide
However, results will vary depending on your starting weight, diet, exercise habits, and how closely you follow your doctors plan
No studies investigating possible interactions between GLP-1RAs and anti-addiction drugs were found